Related by context. Frequent words. (Click for all words.) 78 Phase III Clinical Trial 78 Acute Myocardial Infarction 76 Patients Treated 75 Pulmonary Arterial Hypertension 75 Elderly Patients 75 Pivotal Trial 74 Overactive Bladder 74 Phase III Trial 74 Chronic Heart Failure 73 Thrombolysis 73 Venous Thromboembolism 73 Clinical Trial Results 73 Heart Failure Patients 73 Percutaneous Coronary Intervention 73 Drug Eluting Stents 73 Well Tolerated 72 Metastatic Colorectal Cancer 72 Meta Analysis 72 Monotherapy 71 Solid Tumors 71 Chronic Hepatitis C 71 Pivotal Phase III 71 Natalizumab 71 Cardiovascular Events 71 Tolerability 71 Allergic Rhinitis 71 Pivotal Phase 71 Diabetic Patients 70 Aliskiren 70 Diabetic Macular Edema 70 Combination Therapy 70 Lacosamide 70 Ischemic 70 Myocardial Infarction 70 Adalimumab 70 Metastatic Melanoma 70 Anticoagulation 69 Acute Coronary Syndrome 69 Completes Enrollment 69 Advanced Prostate Cancer 69 Multicenter 69 Preclinical Data 69 Cardiac Resynchronization Therapy 69 Low Dose 69 Drug Candidate 69 Benign Prostatic Hyperplasia 69 Postmenopausal Women 69 Randomized Controlled Trial 69 Patient Enrollment 68 Prostate Cancer Patients 68 Coronary Stent 68 Epratuzumab 68 Clinical Outcomes 68 Stenting 68 Lenalidomide 68 Breast Cancer Treatment 68 Major Depressive Disorder 68 Dasatinib 68 Enoxaparin 68 Trastuzumab 67 Hepatitis C Virus 67 Ischemia 67 Study Demonstrates 67 Significantly Reduces 67 Traficet EN 67 Etanercept 67 Carotid 67 Bevacizumab 67 Congestive Heart Failure 67 tumor lysis syndrome 67 Hormone Therapy 67 Atopic Dermatitis 67 Antihypertensive 67 Pharmacokinetic 66 Systematic Review 66 Anti TNF 66 Capecitabine 66 Blood Flow 66 Prostate Cancer Treatment 66 Presents Positive 66 J Am Coll 66 Targeted Therapy 66 placebo controlled clinical 66 Ventricular 66 Cancer Therapies 66 Drug Eluting Stent 66 PRADAXA 66 Occlusion 66 phase IIb clinical 66 Regimens 66 Extended Release 66 Insulin Resistance 66 Dyslipidemia 66 Cyclosporine 66 Immunogenicity 66 Rheumatoid Arthritis RA 66 Hepatic 65 KRN# 65 FDA Clearance 65 Prophylaxis 65 Infliximab